Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$500.9 - $612.21 $180,824 - $221,007
-361 Closed
0 $0
Q1 2022

May 16, 2022

SELL
$524.0 - $644.92 $3.1 Million - $3.81 Million
-5,913 Reduced 94.25%
361 $213,000
Q4 2021

Feb 15, 2022

BUY
$569.0 - $667.24 $3.33 Million - $3.9 Million
5,850 Added 1379.72%
6,274 $4.19 Million
Q2 2021

Aug 13, 2021

BUY
$441.0 - $508.24 $186,984 - $215,493
424 New
424 $214,000
Q1 2021

May 17, 2021

SELL
$439.85 - $518.83 $2.32 Million - $2.73 Million
-5,271 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$435.06 - $527.66 $1.94 Million - $2.36 Million
4,469 Added 557.23%
5,271 $2.46 Million
Q3 2020

Nov 13, 2020

SELL
$359.77 - $441.52 $2.35 Million - $2.89 Million
-6,537 Reduced 89.07%
802 $354,000
Q2 2020

Aug 13, 2020

BUY
$275.2 - $362.34 $2.02 Million - $2.66 Million
7,339 New
7,339 $2.66 Million
Q3 2019

Nov 14, 2019

SELL
$268.46 - $305.43 $327,521 - $372,624
-1,220 Closed
0 $0
Q2 2019

Aug 14, 2019

SELL
$257.51 - $295.55 $16.4 Million - $18.8 Million
-63,721 Reduced 98.12%
1,220 $358,000
Q1 2019

May 15, 2019

BUY
$212.17 - $273.72 $13.8 Million - $17.8 Million
64,941 New
64,941 $17.8 Million

Others Institutions Holding TMO

About THERMO FISHER SCIENTIFIC INC.


  • Ticker TMO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 391,788,992
  • Market Cap $201B
  • Description
  • Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as di...
More about TMO
Track This Portfolio

Track Tiger Eye Capital LLC Portfolio

Follow Tiger Eye Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tiger Eye Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tiger Eye Capital LLC with notifications on news.